Hypercalcemia Treatment Market to Grow at a 11.2% in Terms of Revenue By 2026
Hospitals remain the largest distribution channel in the hypercalcemia market in terms of revenue contribution, accounting for around 39% share to the global market in 2015. Rapid diagnosis and easy availability of hypercalcemia drugs are key factors attributed to increasing revenue from the hospitals end user segment, and hospitals are expected to continue to remain the largest distribution channel for hypercalcemia treatment in the long-term.
View and Download TOC of Hypercalcemia Treatment Market Research Report@ https://www.futuremarketinsights.com/reports/hypercalcemia-treatment-market/toc
Bisphosphonates product type segment is estimated to continue to account for relatively higher revenue share to the global market, at over 67% in 2016 end. U.S. FDA approval of denosumab (Xgeva) for treating hypercalcemia of malignancy refractory in 2014 has boosted the use of biophosphonates. Glucocorticoids and calcimimetics segments are also anticipated to witness steady revenue growth in the near future.
North America and Western Europe are among the leading markets for hypercalcemia treatment, with the former accounting for revenue share of 46% in 2015. The North America hypercalcemia treatment market is anticipated to be valued at US$ 4.39 Bn in 2017, up from US$ 3.61 Bn in 2015. The market in North America is dominated by the U.S. Higher prevalence of malignancy-related hypercalcemia among cancer patients in North America will continue to influence market growth in the near future.
Request and Download Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1320
Amgen Inc., Novartis AG, and Teva Pharmaceuticals Industries Ltd., Pfizer Inc., and F.Hoffmann-La Roche Ltd. are among the leading players in the global hypercalcemia market. The U.S. remains a lucrative market for majority of leading players; foraying into emerging markets of Asia and Africa is a key focus area for global players.
Long-term Outlook: The global hypercalcemia market is anticipated to register a CAGR of 11.2% in terms of revenue during forecast period 2016–2026, and reach a value of US$ 25.23 Bn by 2026.
Buy Full Hypercalcemia Treatment Market Report@ https://www.futuremarketinsights.com/checkout/1320
About Us –
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hypercalcemia Treatment Market to Grow at a 11.2% in Terms of Revenue By 2026 here
News-ID: 726114 • Views: 74
More Releases from Future Market Insights
How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring
More Releases for Hypercalcemia
Hypercalcemia Treatment Market to Exceed US$ 25,230.2 Mn by 2026
Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of hyperparathyroidism-related hypercalcemia and rising incidence of multiple myeloma are major factors expected to fuel growth of the global hypercalcemia treatment market over the forecast period. Availability of drug therapy alternatives over surgeries and favourable reimbursement policies are key factors expected to fuel global market growth. Request to
Global Hypercalcemia Treatment Market 2017 - AbbVie, Amgen, Merck, Novartis, Fuj …
Apex Market Reports, recently published a detailed market research study focused on the "Hypercalcemia Treatment Market" across the global, regional and country level. The report provides 360° analysis of "Hypercalcemia Treatment Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Hypercalcemia Treatment industry, and estimates the future trend of Hypercalcemia Treatment market
Hypercalcemia Treatment Market - Global Industry Analysis & Opportunity Assessme …
Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast cancer, and myeloma. Early diagnosis of hypercalcemia by hydration and treatment with agents to decrease serum calcium concentrations also known as hypocalcemic
Global Hypercalcemia Treatment Market Research Report
Latest industry research report on: Global Hypercalcemia Treatment Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast
Hypercalcemia Treatment Market worth US$ 25.23 Bn by 2026
Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of hyperparathyroidism-related hypercalcemia and rising incidence of multiple myeloma are major factors expected to fuel growth of the global hypercalcemia treatment market over the forecast period. Availability of drug therapy alternatives over surgeries and favourable reimbursement policies are key factors expected to fuel global market growth. Hospitals remain
Global Hypercalcemia Treatment Market 2017-2021
MarketResearchReports.Biz presents this most up-to-date research on "Global Hypercalcemia Treatment Market 2017-2021" Description Hypercalcemia is a condition in which the calcium level in the blood is above normal. Too much calcium in the blood can weaken the bones, create stones in the kidneys, and interfere with the functioning of the heart and the brain. Hypercalcemia refers to the condition where too much calcium enters the extracellular fluid or when there is insufficient